Remedy Meds semaglutide review
Advertised at $299 and billed at $299 — no gap. Position 15 of 16 on our board.
Updated 2026-09-18
$299 a month flat, medication included, no dose surcharge.
Everything in the structure is defensible. The level is about three times the board floor.
The numbers
| Remedy Meds · semaglutide | |
|---|---|
| Advertised | $299/mo |
| Membership | None |
| Billed | $299/mo |
| Advertised-to-billed gap | None |
| Per year | $3,588 |
| Board position | 15 of 16, cheapest first |
One flat price at every dose, medication included.
Where the gap is
None to report — one price, disclosed, unchanging.
Against the board
About $3,588 a year against $1,188 at the floor.
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $79 | $139 | +$60 | +$54/mo |
| SuperHealthy Rx | $85 | $85 | none | — |
| Likeness Rx | $79 | $139 | +$60 | +$54/mo |
| Ozari Health | $86 | $86 | none | +$1/mo |
| Trimi | $99 | $99 | none | +$14/mo |
| Zealthy | $151 | $151 | none | +$66/mo |
| Mochi Health | $99 | $178 | +$79 | +$93/mo |
| Hims & Hers | $79 | $188 | +$109 | +$103/mo |
How the programme works
Compounded GLP-1 programme with two flat monthly prices that do not change with dose, medication included in the monthly fee.
Verified facts
- Compounded semaglutide priced at $299/month flat, regardless of dose.
- Compounded tirzepatide priced at $399/month flat, regardless of dose.
- First month of tirzepatide discounted to $279, then $399/month.
- Medication is included in the monthly fee rather than billed separately.
- Unlimited clinician access, check-ins and dose adjustments included.
- Branded Zepbound offered at around $1,399/month.
Checked 2026-09-18. This market re-prices without notice — anything older than a month is a starting point, not a quote.
For it
- Genuinely flat pricing — the dose can go to the top of the ladder without the bill moving.
- Unlimited clinician access is included rather than sold as an upgrade.
- Medication is inside the monthly fee, so there is no second bill.
Against it
- Expensive relative to the flat-rate leaders for the same class of medication.
- The $279 first month steps up to $399 on renewal.
Read this bit. The $279 introductory tirzepatide month renews at $399. Budget from the renewal figure.
Score
3.5 out of 5 on our rubric, which is fixed before assessment and published on how we rate.
| Criterion | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 2.9 / 5 |
| Price honesty | 20% | 4 / 5 |
| Clinical support | 20% | 4 / 5 |
| Pharmacy sourcing | 15% | 3.5 / 5 |
| Cancelling | 15% | 3.4 / 5 |
Verdict
Premium pricing with no tricks in it. The desk prefers no tricks; it still notes the number.
More from the desk
- Coreage Rx semaglutide review
Advertised at $79, billed at $139. Position 1 of 16 on our board.
- Likeness Rx semaglutide review
Advertised at $79, billed at $139. Position 3 of 16 on our board.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $139/mo semaglutide.
- Six fee traps
Compare the product, supply period, recurring charge and commitment before treating a headline as the full bill.
- Where the traps are
The biggest advertised-to-billed gaps on our board, and the programmes charging most for the same category of medication.
Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure